

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 5.95391404 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.95391404 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.56459637 |
| 4 | negative thymic T cell selection (GO:0045060) | 4.72546284 |
| 5 | negative T cell selection (GO:0043383) | 4.68770216 |
| 6 | detection of other organism (GO:0098543) | 4.64354508 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.60913331 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.60913331 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.47096386 |
| 10 | response to peptidoglycan (GO:0032494) | 4.46101945 |
| 11 | detection of bacterium (GO:0016045) | 4.33887563 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.33864677 |
| 13 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.33397298 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.28257735 |
| 15 | detection of molecule of bacterial origin (GO:0032490) | 4.22963546 |
| 16 | NIK/NF-kappaB signaling (GO:0038061) | 4.22128656 |
| 17 | T cell migration (GO:0072678) | 4.19333682 |
| 18 | regulation of gamma-delta T cell activation (GO:0046643) | 4.17058122 |
| 19 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.07694748 |
| 20 | detection of external biotic stimulus (GO:0098581) | 4.07494422 |
| 21 | positive thymic T cell selection (GO:0045059) | 4.02275123 |
| 22 | negative regulation of interleukin-12 production (GO:0032695) | 3.99683474 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 3.98823414 |
| 24 | modulation by symbiont of host defense response (GO:0052031) | 3.98823414 |
| 25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.98823414 |
| 26 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.98823414 |
| 27 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.98823414 |
| 28 | modulation by symbiont of host immune response (GO:0052553) | 3.98823414 |
| 29 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.98429854 |
| 30 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.94057400 |
| 31 | thymic T cell selection (GO:0045061) | 3.83770905 |
| 32 | response to muramyl dipeptide (GO:0032495) | 3.70097398 |
| 33 | macrophage activation (GO:0042116) | 3.69257874 |
| 34 | T cell selection (GO:0045058) | 3.67888532 |
| 35 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.63396415 |
| 36 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.62687857 |
| 37 | tolerance induction (GO:0002507) | 3.61895048 |
| 38 | response to interleukin-15 (GO:0070672) | 3.60701161 |
| 39 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.59536334 |
| 40 | positive T cell selection (GO:0043368) | 3.59089199 |
| 41 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.58034883 |
| 42 | detection of biotic stimulus (GO:0009595) | 3.57578673 |
| 43 | activated T cell proliferation (GO:0050798) | 3.55501766 |
| 44 | macrophage activation involved in immune response (GO:0002281) | 3.54543700 |
| 45 | leukocyte aggregation (GO:0070486) | 3.54113370 |
| 46 | negative regulation of T cell mediated immunity (GO:0002710) | 3.52712073 |
| 47 | respiratory burst (GO:0045730) | 3.52533225 |
| 48 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.49839661 |
| 49 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.49680923 |
| 50 | cellular response to interleukin-15 (GO:0071350) | 3.46468254 |
| 51 | regulation of mast cell degranulation (GO:0043304) | 3.39296397 |
| 52 | positive regulation of antigen processing and presentation (GO:0002579) | 3.36037085 |
| 53 | B cell receptor signaling pathway (GO:0050853) | 3.35645350 |
| 54 | myeloid dendritic cell differentiation (GO:0043011) | 3.33783997 |
| 55 | myeloid dendritic cell activation (GO:0001773) | 3.28604864 |
| 56 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.26668116 |
| 57 | neutrophil activation involved in immune response (GO:0002283) | 3.26133450 |
| 58 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.24069199 |
| 59 | regulation of leukocyte degranulation (GO:0043300) | 3.22990975 |
| 60 | regulation of B cell differentiation (GO:0045577) | 3.20042089 |
| 61 | positive regulation of B cell differentiation (GO:0045579) | 3.19929469 |
| 62 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.18704079 |
| 63 | neutrophil mediated immunity (GO:0002446) | 3.18122975 |
| 64 | interferon-gamma production (GO:0032609) | 3.17825766 |
| 65 | myeloid cell activation involved in immune response (GO:0002275) | 3.12436285 |
| 66 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.10148561 |
| 67 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.10025384 |
| 68 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.08930349 |
| 69 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.08607668 |
| 70 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.08283169 |
| 71 | positive regulation of mast cell activation (GO:0033005) | 3.07075536 |
| 72 | regulation of T cell tolerance induction (GO:0002664) | 3.06969374 |
| 73 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.06644714 |
| 74 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.06644625 |
| 75 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.06644625 |
| 76 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.04354423 |
| 77 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.99548113 |
| 78 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.97723002 |
| 79 | lymphocyte migration (GO:0072676) | 2.94112905 |
| 80 | regulation of regulated secretory pathway (GO:1903305) | 2.93245294 |
| 81 | leukocyte cell-cell adhesion (GO:0007159) | 2.91581191 |
| 82 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.91365877 |
| 83 | cellular extravasation (GO:0045123) | 2.90387699 |
| 84 | natural killer cell differentiation (GO:0001779) | 2.89271078 |
| 85 | defense response to protozoan (GO:0042832) | 2.89176761 |
| 86 | regulation of mast cell activation (GO:0033003) | 2.87373469 |
| 87 | T cell costimulation (GO:0031295) | 2.86912086 |
| 88 | T cell receptor signaling pathway (GO:0050852) | 2.84145460 |
| 89 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.83478117 |
| 90 | positive regulation of interleukin-2 production (GO:0032743) | 2.82646057 |
| 91 | mast cell activation (GO:0045576) | 2.82312683 |
| 92 | mature B cell differentiation (GO:0002335) | 2.81342175 |
| 93 | positive regulation of interferon-alpha production (GO:0032727) | 2.80938816 |
| 94 | myeloid leukocyte mediated immunity (GO:0002444) | 2.80530756 |
| 95 | lymphocyte costimulation (GO:0031294) | 2.80463984 |
| 96 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.79934440 |
| 97 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.79100613 |
| 98 | natural killer cell activation (GO:0030101) | 2.79081832 |
| 99 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.78871392 |
| 100 | leukocyte degranulation (GO:0043299) | 2.78786610 |
| 101 | immunoglobulin mediated immune response (GO:0016064) | 2.78453043 |
| 102 | microglial cell activation (GO:0001774) | 2.75538894 |
| 103 | regulation of antigen processing and presentation (GO:0002577) | 2.74195985 |
| 104 | regulation of macrophage cytokine production (GO:0010935) | 2.72287092 |
| 105 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.71149631 |
| 106 | regulation of interferon-alpha production (GO:0032647) | 2.68009654 |
| 107 | interferon-gamma secretion (GO:0072643) | 2.67950774 |
| 108 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.67329505 |
| 109 | negative regulation of phagocytosis (GO:0050765) | 2.67263446 |
| 110 | negative regulation of type 2 immune response (GO:0002829) | 2.66934136 |
| 111 | dendritic cell differentiation (GO:0097028) | 2.66678644 |
| 112 | * neutrophil activation (GO:0042119) | 2.66591726 |
| 113 | response to type I interferon (GO:0034340) | 2.65394757 |
| 114 | cellular response to type I interferon (GO:0071357) | 2.63029364 |
| 115 | type I interferon signaling pathway (GO:0060337) | 2.63029364 |
| 116 | regulation of ARF GTPase activity (GO:0032312) | 2.62599775 |
| 117 | B cell homeostasis (GO:0001782) | 2.62025323 |
| 118 | T cell proliferation (GO:0042098) | 2.61964649 |
| 119 | regulation of tolerance induction (GO:0002643) | 2.61597428 |
| 120 | regulation of ARF protein signal transduction (GO:0032012) | 2.60091638 |
| 121 | * granulocyte activation (GO:0036230) | 2.60069434 |
| 122 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.58090437 |
| 123 | response to host immune response (GO:0052572) | 2.56091881 |
| 124 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.56091881 |
| 125 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.54644675 |
| 126 | response to host (GO:0075136) | 2.54621617 |
| 127 | response to host defenses (GO:0052200) | 2.54621617 |
| 128 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.54621617 |
| 129 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.54052540 |
| 130 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.53525429 |
| 131 | germinal center formation (GO:0002467) | 2.52697624 |
| 132 | positive regulation of Rap GTPase activity (GO:0032854) | 2.52530900 |
| 133 | mast cell degranulation (GO:0043303) | 2.52193705 |
| 134 | mast cell activation involved in immune response (GO:0002279) | 2.52193705 |
| 135 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.51854115 |
| 136 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.51242150 |
| 137 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.50647508 |
| 138 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.50457107 |
| 139 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.50457107 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.13583173 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.03125799 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.25356343 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.08678006 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.32599325 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.24724018 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.18136480 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.16155751 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.14387189 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.13710567 |
| 11 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.08942130 |
| 12 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.99061239 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.82395101 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.76456531 |
| 15 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.73382670 |
| 16 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.59632715 |
| 17 | MYC_22102868_ChIP-Seq_BL_Human | 2.59404642 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.40362337 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.39918884 |
| 20 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.37262370 |
| 21 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.36532449 |
| 22 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.35575650 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 2.33533651 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.29019552 |
| 25 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.22509185 |
| 26 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.21037612 |
| 27 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.17893282 |
| 28 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.16520425 |
| 29 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.11535045 |
| 30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.06349599 |
| 31 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.06242374 |
| 32 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.99110321 |
| 33 | MYB_26560356_Chip-Seq_TH1_Human | 1.93314253 |
| 34 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.93208127 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.92700825 |
| 36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.92525948 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.88554522 |
| 38 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.82452467 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.79325972 |
| 40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.75513729 |
| 41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75019921 |
| 42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.73528737 |
| 43 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.73312529 |
| 44 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.70746523 |
| 45 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.66452976 |
| 46 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.64936338 |
| 47 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.64299595 |
| 48 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.61734141 |
| 49 | * SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.61670528 |
| 50 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.59575569 |
| 51 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.58210301 |
| 52 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.57833463 |
| 53 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.57550288 |
| 54 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.45729330 |
| 55 | MAF_26560356_Chip-Seq_TH2_Human | 1.45711252 |
| 56 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.44562541 |
| 57 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.38690268 |
| 58 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.38014293 |
| 59 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33381782 |
| 60 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.33159895 |
| 61 | KDM2B_26808549_Chip-Seq_K562_Human | 1.29458040 |
| 62 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26889230 |
| 63 | GATA1_19941826_ChIP-Seq_K562_Human | 1.26184277 |
| 64 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26162610 |
| 65 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.24723985 |
| 66 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23831534 |
| 67 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.22730613 |
| 68 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.21688075 |
| 69 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.21501210 |
| 70 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.16238115 |
| 71 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14625280 |
| 72 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.14316391 |
| 73 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.14257758 |
| 74 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12887457 |
| 75 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12288114 |
| 76 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.06805258 |
| 77 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06555913 |
| 78 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06325481 |
| 79 | GATA2_19941826_ChIP-Seq_K562_Human | 1.02082741 |
| 80 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01010525 |
| 81 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99794703 |
| 82 | GATA3_26560356_Chip-Seq_TH2_Human | 0.99222988 |
| 83 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.99218770 |
| 84 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97962471 |
| 85 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.97917025 |
| 86 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.97885091 |
| 87 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.94749794 |
| 88 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92993977 |
| 89 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.91447935 |
| 90 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.90951292 |
| 91 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90830151 |
| 92 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90056661 |
| 93 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89907621 |
| 94 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.88404031 |
| 95 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.86179069 |
| 96 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85540925 |
| 97 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.84671245 |
| 98 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.84345625 |
| 99 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.83082974 |
| 100 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.80678802 |
| 101 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.80276205 |
| 102 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.80082359 |
| 103 | GATA1_22025678_ChIP-Seq_K562_Human | 0.79255331 |
| 104 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.79182977 |
| 105 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78995860 |
| 106 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.75080157 |
| 107 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.73418401 |
| 108 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72332235 |
| 109 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.72247668 |
| 110 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.71574423 |
| 111 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.71176712 |
| 112 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70122824 |
| 113 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.69807838 |
| 114 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.67523759 |
| 115 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.67178923 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.92861542 |
| 2 | MP0005671_abnormal_response_to | 3.38691992 |
| 3 | MP0004510_myositis | 3.37148111 |
| 4 | MP0003303_peritoneal_inflammation | 3.27884857 |
| 5 | MP0000685_abnormal_immune_system | 3.25002220 |
| 6 | MP0005387_immune_system_phenotype | 2.99015906 |
| 7 | MP0001790_abnormal_immune_system | 2.99015906 |
| 8 | MP0001800_abnormal_humoral_immune | 2.90613146 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.81379916 |
| 10 | MP0002452_abnormal_antigen_presenting | 2.68273943 |
| 11 | MP0002723_abnormal_immune_serum | 2.61562205 |
| 12 | MP0003436_decreased_susceptibility_to | 2.61086421 |
| 13 | MP0008260_abnormal_autophagy | 2.53735971 |
| 14 | * MP0002420_abnormal_adaptive_immunity | 2.53394183 |
| 15 | * MP0001819_abnormal_immune_cell | 2.53343675 |
| 16 | MP0006082_CNS_inflammation | 2.51152545 |
| 17 | * MP0002419_abnormal_innate_immunity | 2.48717129 |
| 18 | MP0003763_abnormal_thymus_physiology | 2.46399290 |
| 19 | MP0000569_abnormal_digit_pigmentation | 2.41483507 |
| 20 | MP0003300_gastrointestinal_ulcer | 2.37366571 |
| 21 | MP0002166_altered_tumor_susceptibility | 2.32596960 |
| 22 | MP0009785_altered_susceptibility_to | 2.31246651 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 2.30917989 |
| 24 | MP0005025_abnormal_response_to | 2.30146618 |
| 25 | MP0003172_abnormal_lysosome_physiology | 2.25110143 |
| 26 | MP0002398_abnormal_bone_marrow | 2.17828730 |
| 27 | MP0004381_abnormal_hair_follicle | 2.08600432 |
| 28 | * MP0000716_abnormal_immune_system | 2.03668993 |
| 29 | MP0005464_abnormal_platelet_physiology | 2.02186695 |
| 30 | MP0002006_tumorigenesis | 1.99670650 |
| 31 | MP0004859_abnormal_synaptic_plasticity | 1.97617679 |
| 32 | MP0005058_abnormal_lysosome_morphology | 1.94694322 |
| 33 | MP0002405_respiratory_system_inflammati | 1.92786066 |
| 34 | MP0001873_stomach_inflammation | 1.90911611 |
| 35 | MP0009278_abnormal_bone_marrow | 1.90185708 |
| 36 | MP0005310_abnormal_salivary_gland | 1.89326523 |
| 37 | MP0005451_abnormal_body_composition | 1.81694685 |
| 38 | MP0004947_skin_inflammation | 1.81475886 |
| 39 | MP0003828_pulmonary_edema | 1.74408812 |
| 40 | MP0002722_abnormal_immune_system | 1.66934067 |
| 41 | MP0000689_abnormal_spleen_morphology | 1.66407377 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.59566162 |
| 43 | * MP0002429_abnormal_blood_cell | 1.58687473 |
| 44 | MP0000703_abnormal_thymus_morphology | 1.58545009 |
| 45 | MP0002396_abnormal_hematopoietic_system | 1.51191185 |
| 46 | MP0003183_abnormal_peptide_metabolism | 1.50678825 |
| 47 | MP0001845_abnormal_inflammatory_respons | 1.48519375 |
| 48 | MP0004883_abnormal_blood_vessel | 1.47715789 |
| 49 | MP0003075_altered_response_to | 1.45906166 |
| 50 | MP0002254_reproductive_system_inflammat | 1.45555720 |
| 51 | MP0002138_abnormal_hepatobiliary_system | 1.41588552 |
| 52 | MP0003448_altered_tumor_morphology | 1.41529271 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.37878258 |
| 54 | MP0004808_abnormal_hematopoietic_stem | 1.37342925 |
| 55 | MP0003690_abnormal_glial_cell | 1.36831038 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.34674231 |
| 57 | MP0000604_amyloidosis | 1.34628900 |
| 58 | MP0001853_heart_inflammation | 1.32954065 |
| 59 | MP0005397_hematopoietic_system_phenotyp | 1.31662000 |
| 60 | MP0001545_abnormal_hematopoietic_system | 1.31662000 |
| 61 | MP0005174_abnormal_tail_pigmentation | 1.31428510 |
| 62 | MP0002998_abnormal_bone_remodeling | 1.30861627 |
| 63 | MP0003866_abnormal_defecation | 1.29426078 |
| 64 | MP0008961_abnormal_basal_metabolism | 1.26020795 |
| 65 | MP0002132_abnormal_respiratory_system | 1.25222714 |
| 66 | MP0005076_abnormal_cell_differentiation | 1.20766716 |
| 67 | MP0003724_increased_susceptibility_to | 1.13476424 |
| 68 | MP0005167_abnormal_blood-brain_barrier | 1.13282186 |
| 69 | MP0001851_eye_inflammation | 1.12563538 |
| 70 | MP0002933_joint_inflammation | 1.11466443 |
| 71 | MP0003705_abnormal_hypodermis_morpholog | 1.10798455 |
| 72 | MP0005075_abnormal_melanosome_morpholog | 1.09181759 |
| 73 | MP0003191_abnormal_cellular_cholesterol | 1.08253345 |
| 74 | MP0000465_gastrointestinal_hemorrhage | 1.07849042 |
| 75 | MP0000920_abnormal_myelination | 1.07204925 |
| 76 | MP0008469_abnormal_protein_level | 1.06677263 |
| 77 | MP0002009_preneoplasia | 1.05785286 |
| 78 | MP0003091_abnormal_cell_migration | 1.02093900 |
| 79 | MP0005166_decreased_susceptibility_to | 0.97579445 |
| 80 | MP0009840_abnormal_foam_cell | 0.97019252 |
| 81 | MP0000858_altered_metastatic_potential | 0.96305109 |
| 82 | MP0004858_abnormal_nervous_system | 0.93471679 |
| 83 | MP0004264_abnormal_extraembryonic_tissu | 0.88028276 |
| 84 | MP0005164_abnormal_response_to | 0.87016429 |
| 85 | MP0003045_fibrosis | 0.85959011 |
| 86 | MP0010307_abnormal_tumor_latency | 0.84779575 |
| 87 | MP0008569_lethality_at_weaning | 0.83605220 |
| 88 | MP0001348_abnormal_lacrimal_gland | 0.79913504 |
| 89 | MP0002064_seizures | 0.78851396 |
| 90 | MP0003453_abnormal_keratinocyte_physiol | 0.78419386 |
| 91 | MP0000015_abnormal_ear_pigmentation | 0.77592128 |
| 92 | MP0003635_abnormal_synaptic_transmissio | 0.75852192 |
| 93 | MP0005390_skeleton_phenotype | 0.75392451 |
| 94 | MP0005409_darkened_coat_color | 0.73615242 |
| 95 | MP0003633_abnormal_nervous_system | 0.72502191 |
| 96 | MP0004130_abnormal_muscle_cell | 0.71864128 |
| 97 | MP0009764_decreased_sensitivity_to | 0.70606433 |
| 98 | MP0000343_altered_response_to | 0.70119676 |
| 99 | MP0005248_abnormal_Harderian_gland | 0.67985938 |
| 100 | MP0003656_abnormal_erythrocyte_physiolo | 0.67671973 |
| 101 | MP0008874_decreased_physiological_sensi | 0.66596853 |
| 102 | MP0000249_abnormal_blood_vessel | 0.64455471 |
| 103 | MP0002332_abnormal_exercise_endurance | 0.64411237 |
| 104 | MP0005388_respiratory_system_phenotype | 0.62595905 |
| 105 | MP0002133_abnormal_respiratory_system | 0.62595905 |
| 106 | MP0005423_abnormal_somatic_nervous | 0.62527009 |
| 107 | MP0003795_abnormal_bone_structure | 0.62423520 |
| 108 | MP0010352_gastrointestinal_tract_polyps | 0.61997501 |
| 109 | MP0003329_amyloid_beta_deposits | 0.61781450 |
| 110 | MP0003787_abnormal_imprinting | 0.61433284 |
| 111 | MP0009763_increased_sensitivity_to | 0.60760522 |
| 112 | MP0003221_abnormal_cardiomyocyte_apopto | 0.60709153 |
| 113 | MP0009745_abnormal_behavioral_response | 0.59139490 |
| 114 | MP0002277_abnormal_respiratory_mucosa | 0.58672767 |
| 115 | MP0003566_abnormal_cell_adhesion | 0.57774570 |
| 116 | MP0003634_abnormal_glial_cell | 0.55490577 |
| 117 | MP0001663_abnormal_digestive_system | 0.53824374 |
| 118 | MP0000371_diluted_coat_color | 0.51520010 |
| 119 | MP0001501_abnormal_sleep_pattern | 0.50126072 |
| 120 | MP0000490_abnormal_crypts_of | 0.49673238 |
| 121 | MP0004185_abnormal_adipocyte_glucose | 0.49029081 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.71809723 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.59363701 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.39978803 |
| 4 | Recurrent fungal infections (HP:0002841) | 4.19633655 |
| 5 | Recurrent viral infections (HP:0004429) | 4.03568762 |
| 6 | Myositis (HP:0100614) | 3.87392216 |
| 7 | Chronic otitis media (HP:0000389) | 3.80275474 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.67630752 |
| 9 | Increased cerebral lipofuscin (HP:0011813) | 3.40259173 |
| 10 | T lymphocytopenia (HP:0005403) | 3.38822395 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 3.34408870 |
| 12 | Abnormality of T cell number (HP:0011839) | 3.34206974 |
| 13 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.31181171 |
| 14 | Recurrent cutaneous fungal infections (HP:0011370) | 3.31181171 |
| 15 | Abnormality of macrophages (HP:0004311) | 3.29370164 |
| 16 | Recurrent skin infections (HP:0001581) | 3.26275656 |
| 17 | Optic neuritis (HP:0100653) | 3.26270343 |
| 18 | Retrobulbar optic neuritis (HP:0100654) | 3.26270343 |
| 19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.19903387 |
| 20 | Orchitis (HP:0100796) | 3.19731984 |
| 21 | Nasal polyposis (HP:0100582) | 3.08962791 |
| 22 | Panhypogammaglobulinemia (HP:0003139) | 3.00476489 |
| 23 | Colitis (HP:0002583) | 3.00114536 |
| 24 | Inflammation of the large intestine (HP:0002037) | 2.94264379 |
| 25 | Cellulitis (HP:0100658) | 2.91625099 |
| 26 | Stomatitis (HP:0010280) | 2.91214524 |
| 27 | Vasculitis (HP:0002633) | 2.87328374 |
| 28 | Meningitis (HP:0001287) | 2.86930880 |
| 29 | Autoimmune thrombocytopenia (HP:0001973) | 2.86611289 |
| 30 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.85829781 |
| 31 | Spontaneous hematomas (HP:0007420) | 2.85083487 |
| 32 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.84026949 |
| 33 | Gastrointestinal inflammation (HP:0004386) | 2.83557908 |
| 34 | Urticaria (HP:0001025) | 2.83053086 |
| 35 | Hematochezia (HP:0002573) | 2.81536921 |
| 36 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.80593354 |
| 37 | Abnormality of the fingertips (HP:0001211) | 2.79407883 |
| 38 | Eosinophilia (HP:0001880) | 2.78321867 |
| 39 | Abnormality of the nasal mucosa (HP:0000433) | 2.77788906 |
| 40 | Increased IgE level (HP:0003212) | 2.77521518 |
| 41 | Obstructive lung disease (HP:0006536) | 2.74339973 |
| 42 | Chronic obstructive pulmonary disease (HP:0006510) | 2.74339973 |
| 43 | Leukocytosis (HP:0001974) | 2.71812613 |
| 44 | IgM deficiency (HP:0002850) | 2.69447353 |
| 45 | Recurrent bronchitis (HP:0002837) | 2.68201756 |
| 46 | Thyroiditis (HP:0100646) | 2.62783188 |
| 47 | Pulmonary infiltrates (HP:0002113) | 2.62640125 |
| 48 | Pulmonary embolism (HP:0002204) | 2.59900831 |
| 49 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.59570821 |
| 50 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.59570821 |
| 51 | Abnormality of glycolipid metabolism (HP:0010969) | 2.59570821 |
| 52 | Abnormality of T cells (HP:0002843) | 2.57422032 |
| 53 | Fatigue (HP:0012378) | 2.56362071 |
| 54 | Slow saccadic eye movements (HP:0000514) | 2.55820267 |
| 55 | Gingivitis (HP:0000230) | 2.54722737 |
| 56 | Agammaglobulinemia (HP:0004432) | 2.51682574 |
| 57 | Hypochromic anemia (HP:0001931) | 2.49727547 |
| 58 | Hemiplegia (HP:0002301) | 2.48560454 |
| 59 | Abnormality of eosinophils (HP:0001879) | 2.47836796 |
| 60 | Pustule (HP:0200039) | 2.45090703 |
| 61 | Arterial thrombosis (HP:0004420) | 2.44662197 |
| 62 | Amyloidosis (HP:0011034) | 2.40588517 |
| 63 | Systemic lupus erythematosus (HP:0002725) | 2.40135079 |
| 64 | Periodontitis (HP:0000704) | 2.38751064 |
| 65 | Epistaxis (HP:0000421) | 2.36673767 |
| 66 | Episodic fever (HP:0001954) | 2.32390829 |
| 67 | Hypochromic microcytic anemia (HP:0004840) | 2.30800067 |
| 68 | Hemoptysis (HP:0002105) | 2.28366181 |
| 69 | Supranuclear gaze palsy (HP:0000605) | 2.26782733 |
| 70 | Loss of speech (HP:0002371) | 2.25445747 |
| 71 | Chest pain (HP:0100749) | 2.24110301 |
| 72 | Viral hepatitis (HP:0006562) | 2.22439281 |
| 73 | Dysostosis multiplex (HP:0000943) | 2.21083305 |
| 74 | Sepsis (HP:0100806) | 2.20052144 |
| 75 | Granulocytopenia (HP:0001913) | 2.19360595 |
| 76 | Peritonitis (HP:0002586) | 2.17760552 |
| 77 | Disinhibition (HP:0000734) | 2.16097070 |
| 78 | Anorexia (HP:0002039) | 2.15974500 |
| 79 | Severe combined immunodeficiency (HP:0004430) | 2.15113965 |
| 80 | Verrucae (HP:0200043) | 2.14501327 |
| 81 | Papilloma (HP:0012740) | 2.14501327 |
| 82 | Abnormality of the endocardium (HP:0004306) | 2.14236874 |
| 83 | Abnormality of binocular vision (HP:0011514) | 2.09066517 |
| 84 | Diplopia (HP:0000651) | 2.09066517 |
| 85 | Subacute progressive viral hepatitis (HP:0006572) | 2.06650081 |
| 86 | Lymphopenia (HP:0001888) | 2.02912084 |
| 87 | Increased IgM level (HP:0003496) | 2.00869183 |
| 88 | Hypergammaglobulinemia (HP:0010702) | 2.00434085 |
| 89 | Interstitial pulmonary disease (HP:0006530) | 2.00364222 |
| 90 | Abnormality of the pleura (HP:0002103) | 1.98977254 |
| 91 | Abnormality of the peritoneum (HP:0002585) | 1.98922760 |
| 92 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.98840155 |
| 93 | Vertigo (HP:0002321) | 1.98519556 |
| 94 | Keratoconjunctivitis sicca (HP:0001097) | 1.98237484 |
| 95 | Cerebral aneurysm (HP:0004944) | 1.96316903 |
| 96 | Combined immunodeficiency (HP:0005387) | 1.95396353 |
| 97 | Encephalitis (HP:0002383) | 1.93815644 |
| 98 | Chronic diarrhea (HP:0002028) | 1.93733658 |
| 99 | Papilledema (HP:0001085) | 1.92914722 |
| 100 | Gangrene (HP:0100758) | 1.92691566 |
| 101 | Hyperacusis (HP:0010780) | 1.91562272 |
| 102 | Microcytic anemia (HP:0001935) | 1.89697582 |
| 103 | Emphysema (HP:0002097) | 1.88304188 |
| 104 | Keratoconjunctivitis (HP:0001096) | 1.87059123 |
| 105 | Absent frontal sinuses (HP:0002688) | 1.86614113 |
| 106 | Metaphyseal cupping (HP:0003021) | 1.86017850 |
| 107 | Arterial tortuosity (HP:0005116) | 1.85687670 |
| 108 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.84882490 |
| 109 | Chronic sinusitis (HP:0011109) | 1.84170234 |
| 110 | Osteomyelitis (HP:0002754) | 1.83044006 |
| 111 | Abnormality of B cell number (HP:0010975) | 1.82504206 |
| 112 | B lymphocytopenia (HP:0010976) | 1.82504206 |
| 113 | Mutism (HP:0002300) | 1.82217423 |
| 114 | Gastrointestinal infarctions (HP:0005244) | 1.81713669 |
| 115 | Frequent falls (HP:0002359) | 1.80946348 |
| 116 | Gastrointestinal stroma tumor (HP:0100723) | 1.80923685 |
| 117 | Glomerulopathy (HP:0100820) | 1.80665781 |
| 118 | Micronodular cirrhosis (HP:0001413) | 1.80664054 |
| 119 | Abnormality of T cell physiology (HP:0011840) | 1.80541212 |
| 120 | Difficulty running (HP:0009046) | 1.79497782 |
| 121 | Restrictive lung disease (HP:0002091) | 1.79421481 |
| 122 | Skin ulcer (HP:0200042) | 1.78952451 |
| 123 | Prolonged bleeding time (HP:0003010) | 1.76074355 |
| 124 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.75911916 |
| 125 | Neuronal loss in central nervous system (HP:0002529) | 1.75666416 |
| 126 | Apathy (HP:0000741) | 1.75457460 |
| 127 | Basal ganglia calcification (HP:0002135) | 1.75192239 |
| 128 | Acne (HP:0001061) | 1.74660160 |
| 129 | Gingival bleeding (HP:0000225) | 1.73911976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.05208506 |
| 2 | MAP3K13 | 2.96725381 |
| 3 | TYK2 | 2.94810518 |
| 4 | PRPF4B | 2.91696921 |
| 5 | RIPK4 | 2.82221496 |
| 6 | MAP3K14 | 2.72838834 |
| 7 | TXK | 2.48078470 |
| 8 | JAK3 | 2.43798339 |
| 9 | JAK1 | 2.42140168 |
| 10 | TBK1 | 2.22742197 |
| 11 | EPHB1 | 2.19053549 |
| 12 | BLK | 2.13781826 |
| 13 | IKBKE | 2.04514588 |
| 14 | FES | 2.02285960 |
| 15 | SIK2 | 1.96474007 |
| 16 | IRAK4 | 1.88152084 |
| 17 | CSF1R | 1.77191866 |
| 18 | ITK | 1.76335209 |
| 19 | MAP3K10 | 1.75149964 |
| 20 | TGFBR2 | 1.72880265 |
| 21 | STK10 | 1.71756764 |
| 22 | TRIB3 | 1.64674666 |
| 23 | IKBKB | 1.62886133 |
| 24 | KIT | 1.53650406 |
| 25 | ZAP70 | 1.53252914 |
| 26 | HCK | 1.52974834 |
| 27 | GRK6 | 1.51796231 |
| 28 | FGFR3 | 1.51453785 |
| 29 | CSK | 1.49127905 |
| 30 | CLK1 | 1.48741957 |
| 31 | SYK | 1.45488063 |
| 32 | FGFR4 | 1.41970782 |
| 33 | SIK1 | 1.41722990 |
| 34 | EEF2K | 1.41057135 |
| 35 | MAP3K3 | 1.37357455 |
| 36 | LCK | 1.27916366 |
| 37 | SMG1 | 1.24395820 |
| 38 | CHUK | 1.19730053 |
| 39 | BTK | 1.19184887 |
| 40 | JAK2 | 1.18481221 |
| 41 | MAP3K9 | 1.17667783 |
| 42 | MAP3K11 | 1.16328644 |
| 43 | TYRO3 | 1.15968117 |
| 44 | YES1 | 1.15145123 |
| 45 | IRAK3 | 1.09683612 |
| 46 | PTK6 | 1.01572456 |
| 47 | CAMK1G | 0.99050929 |
| 48 | PKN2 | 0.98642416 |
| 49 | PRKCH | 0.97496702 |
| 50 | ALK | 0.92908713 |
| 51 | KSR2 | 0.91465938 |
| 52 | BMPR2 | 0.91230169 |
| 53 | RIPK1 | 0.89532042 |
| 54 | CAMKK1 | 0.88757919 |
| 55 | MARK3 | 0.88051509 |
| 56 | CAMK1D | 0.86971376 |
| 57 | DMPK | 0.86497387 |
| 58 | TESK2 | 0.86308532 |
| 59 | PRKD2 | 0.84018692 |
| 60 | PRKCQ | 0.83947319 |
| 61 | RET | 0.82935965 |
| 62 | NEK6 | 0.81860855 |
| 63 | FGR | 0.79666303 |
| 64 | PDK1 | 0.79367236 |
| 65 | PKN1 | 0.77830941 |
| 66 | STK11 | 0.75035441 |
| 67 | SGK3 | 0.73820954 |
| 68 | NTRK2 | 0.73811965 |
| 69 | DAPK2 | 0.73582629 |
| 70 | LRRK2 | 0.73500670 |
| 71 | PDGFRB | 0.71565937 |
| 72 | LYN | 0.70039118 |
| 73 | CDC42BPA | 0.66986388 |
| 74 | TEC | 0.66431881 |
| 75 | MAP3K2 | 0.66190872 |
| 76 | TAOK3 | 0.66059764 |
| 77 | MATK | 0.65622122 |
| 78 | TAOK2 | 0.65156723 |
| 79 | EPHA3 | 0.64288164 |
| 80 | HIPK2 | 0.63365162 |
| 81 | MAP3K7 | 0.62315938 |
| 82 | TAOK1 | 0.62075479 |
| 83 | TNK2 | 0.60953802 |
| 84 | PIM1 | 0.60852998 |
| 85 | MAPK7 | 0.60538632 |
| 86 | SGK2 | 0.59877875 |
| 87 | MAP2K2 | 0.58831961 |
| 88 | CDK12 | 0.58225096 |
| 89 | RPS6KC1 | 0.55094714 |
| 90 | RPS6KL1 | 0.55094714 |
| 91 | FYN | 0.54972800 |
| 92 | PAK6 | 0.54407284 |
| 93 | ERN1 | 0.54225063 |
| 94 | NLK | 0.53379662 |
| 95 | RPS6KA2 | 0.53314704 |
| 96 | IRAK1 | 0.51641946 |
| 97 | DYRK1B | 0.50984713 |
| 98 | MAP3K6 | 0.48559397 |
| 99 | BMX | 0.48190484 |
| 100 | PDPK1 | 0.48169367 |
| 101 | PTK2B | 0.44348064 |
| 102 | MAPK12 | 0.44333935 |
| 103 | MAP2K3 | 0.43552164 |
| 104 | NEK9 | 0.43087501 |
| 105 | RPS6KA6 | 0.42816317 |
| 106 | CDK6 | 0.42411870 |
| 107 | PRKD1 | 0.42251150 |
| 108 | RAF1 | 0.41537342 |
| 109 | MAP2K4 | 0.40322092 |
| 110 | SIK3 | 0.40163985 |
| 111 | CDK5 | 0.39427496 |
| 112 | RPS6KA4 | 0.39403042 |
| 113 | EGFR | 0.39252327 |
| 114 | SCYL2 | 0.39213450 |
| 115 | MARK2 | 0.37782170 |
| 116 | MAP3K1 | 0.36300027 |
| 117 | STK38 | 0.35586819 |
| 118 | PRKAA2 | 0.35450066 |
| 119 | IRAK2 | 0.35375292 |
| 120 | CDK9 | 0.35057383 |
| 121 | SGK1 | 0.35027708 |
| 122 | MOS | 0.32423288 |
| 123 | ICK | 0.32193408 |
| 124 | ABL1 | 0.30598480 |
| 125 | MELK | 0.30214511 |
| 126 | MAPKAPK2 | 0.29886453 |
| 127 | SRC | 0.29066598 |
| 128 | KSR1 | 0.28564959 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.32652993 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.21579720 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.21028541 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.15945550 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.04499054 |
| 6 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.93865116 |
| 7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.93124935 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.92623602 |
| 9 | Measles_Homo sapiens_hsa05162 | 1.74553596 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.70987287 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.66493626 |
| 12 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.63111524 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.61126725 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.56962041 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.56425380 |
| 16 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49671499 |
| 17 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.46254155 |
| 18 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.44951942 |
| 19 | Allograft rejection_Homo sapiens_hsa05330 | 1.43836295 |
| 20 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.43728896 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.43404434 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.39621914 |
| 23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.36708680 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.33655535 |
| 25 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.28360591 |
| 26 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.28268096 |
| 27 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.24877717 |
| 28 | Pertussis_Homo sapiens_hsa05133 | 1.24260408 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.24175590 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.21511782 |
| 31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.20791731 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.20460060 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.19300365 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.19246772 |
| 35 | Apoptosis_Homo sapiens_hsa04210 | 1.19123043 |
| 36 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.15910040 |
| 37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.15461163 |
| 38 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.11502065 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.10209971 |
| 40 | Platelet activation_Homo sapiens_hsa04611 | 1.06311140 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.04983018 |
| 42 | Phagosome_Homo sapiens_hsa04145 | 1.04459446 |
| 43 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.02859522 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.01834891 |
| 45 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.99408432 |
| 46 | Salmonella infection_Homo sapiens_hsa05132 | 0.99230449 |
| 47 | Lysosome_Homo sapiens_hsa04142 | 0.99176633 |
| 48 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.95552740 |
| 49 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.95403728 |
| 50 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.94718642 |
| 51 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.94659385 |
| 52 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.94115094 |
| 53 | Olfactory transduction_Homo sapiens_hsa04740 | 0.93714502 |
| 54 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.93227844 |
| 55 | Endocytosis_Homo sapiens_hsa04144 | 0.90714279 |
| 56 | Malaria_Homo sapiens_hsa05144 | 0.89973298 |
| 57 | Colorectal cancer_Homo sapiens_hsa05210 | 0.89316731 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.89141516 |
| 59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85711661 |
| 60 | Glioma_Homo sapiens_hsa05214 | 0.84472096 |
| 61 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.84065150 |
| 62 | Legionellosis_Homo sapiens_hsa05134 | 0.82999153 |
| 63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.82199407 |
| 64 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.79847150 |
| 65 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.78653925 |
| 66 | Hepatitis C_Homo sapiens_hsa05160 | 0.78048389 |
| 67 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.77808448 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76936081 |
| 69 | Asthma_Homo sapiens_hsa05310 | 0.76570459 |
| 70 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.76157111 |
| 71 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.74941138 |
| 72 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.74819041 |
| 73 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.74179791 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74162002 |
| 75 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72449242 |
| 76 | Morphine addiction_Homo sapiens_hsa05032 | 0.71455484 |
| 77 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71346782 |
| 78 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.71272912 |
| 79 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.70497095 |
| 80 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.69070382 |
| 81 | Long-term potentiation_Homo sapiens_hsa04720 | 0.68581647 |
| 82 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.68360754 |
| 83 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.68030100 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68015497 |
| 85 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68009384 |
| 86 | Other glycan degradation_Homo sapiens_hsa00511 | 0.67809570 |
| 87 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.67281580 |
| 88 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.67212339 |
| 89 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.66962871 |
| 90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65171396 |
| 91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64971390 |
| 92 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64721389 |
| 93 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.64160660 |
| 94 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.63910781 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63709848 |
| 96 | HTLV-I infection_Homo sapiens_hsa05166 | 0.63666542 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.63595703 |
| 98 | Prostate cancer_Homo sapiens_hsa05215 | 0.63433219 |
| 99 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.63366319 |
| 100 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.63268849 |
| 101 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63119723 |
| 102 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.63020182 |
| 103 | Salivary secretion_Homo sapiens_hsa04970 | 0.62409732 |
| 104 | Amoebiasis_Homo sapiens_hsa05146 | 0.61804774 |
| 105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.61276789 |
| 106 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61003355 |
| 107 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.60886821 |
| 108 | Endometrial cancer_Homo sapiens_hsa05213 | 0.60655289 |
| 109 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59961517 |
| 110 | Renin secretion_Homo sapiens_hsa04924 | 0.59639793 |
| 111 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.59277781 |
| 112 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.58265969 |
| 113 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58013416 |
| 114 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56200406 |
| 115 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.55427830 |
| 116 | Thyroid cancer_Homo sapiens_hsa05216 | 0.54288664 |

